Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Deep Vein Thrombosis Clinical Trials
Deep Vein Thrombosis clinical trials are recruiting across 75 cities. Here are the cities with the most active studies:
Deep Vein Thrombosis Trial Phases
23 research organizations are sponsoring deep vein thrombosis trials.
About Deep Vein Thrombosis
Deep vein thrombosis (DVT) occurs when a blood clot forms in a deep vein, usually in the legs. It can be dangerous if the clot breaks loose and travels to the lungs (pulmonary embolism). Treatment includes blood thinners and sometimes clot-removal procedures.
Clinical trials are advancing new treatments for deep vein thrombosis. Currently, 26 studies are recruiting a combined 154,724 participants across the United States. Research is being conducted by 23 organizations including Manuel Monreal, Mayo Clinic, University of Miami and 20 others.
2026 Deep Vein Thrombosis Research Landscape
As of July 2026, the deep vein thrombosis clinical trial landscape includes 26 actively recruiting studies across 75 cities in the United States. These studies are collectively seeking 154,724 participants, with an average enrollment target of 5,951 per study.
The research spans multiple phases of development: 7 studies are in NA, 5 studies are in PHASE3, 3 studies are in PHASE2, 2 studies are in PHASE4, 1 study is in EARLY_PHASE1. The presence of Phase 3 trials indicates that some deep vein thrombosis treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 23 different organizations, including Manuel Monreal, Mayo Clinic, University of Miami, Stanford University, Brigham and Women's Hospital, and 18 others. The large number of sponsors reflects significant research interest and investment in deep vein thrombosis treatment advancement.
Geographically, deep vein thrombosis trials are most concentrated in Boston, Massachusetts (5 trials); New Haven, Connecticut (3 trials); Jacksonville, Florida (3 trials); Tampa, Florida (3 trials); New York, New York (3 trials) and 7 other cities.
Featured Deep Vein Thrombosis Studies
Highlighted recruiting studies for deep vein thrombosis, selected by enrollment size and research scope.
Computerized Registry of Patients With Venous Thromboembolism (RIETE)
The Computerized Registry of Patients with Venous Thromboembolism (RIETE) is a multidisciplinary Project initiated in march 2001 and consisting in obtaining an extensive data registry of consecutive patients with venous thromboembolism. The main objective is to provide information on the Internet to help physicians to improve their knowledge on the natural history of thromboembolic disease, parti...
Registry of Patients Prescribed Anticoagulation
The Gonda Vascular Center- Thrombophilia Clinic at Mayo Clinic in Rochester, Minnesota utilizes a standardized, guideline-directed, yet patient-oriented approach for treating patients diagnosed with venous thromboembolism (VTE).This study is the ongoing registry of clinical practice with standardized approach to patient assessment and therapy. As most of registries it does not have any definite nu...
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
This research study is attempting to answer the question of whether 81 mg aspirin once daily is as effective as 81 mg aspirin twice daily in preventing blood clots after total joint replacement surgery.
Frequently Asked Questions About Deep Vein Thrombosis Clinical Trials
Are there deep vein thrombosis clinical trials near me?
Yes, there are 26 deep vein thrombosis clinical trials currently recruiting across 75+ cities in the United States, including Boston, Massachusetts; New Haven, Connecticut; Jacksonville, Florida. Browse the studies above to find one at a location convenient for you.
How do I join a deep vein thrombosis clinical trial?
To join a deep vein thrombosis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are deep vein thrombosis clinical trials free?
Yes, participation in deep vein thrombosis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of deep vein thrombosis treatments are being studied?
Current deep vein thrombosis clinical trials are testing a range of approaches across NA (7 studies), PHASE3 (5 studies), PHASE2 (3 studies), PHASE4 (2 studies), EARLY_PHASE1 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 23 research organizations.
Is it safe to participate in deep vein thrombosis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov